Rhea-AI Summary
Ives Ultra AI Opportunities (IVAI) priced its initial public offering at $200 million to fund access to private AI companies. The offering comprises 20,000,000 common shares at $10.00 each, with an underwriter option to purchase up to 3,000,000 additional shares for overallotments.
The closed-end investment fund has up to 12 months to propose its initial private AI investments and provide investors an opportunity to tender their shares under its Tender Offer Policy. Trading on the NYSE is expected to begin September 30, 2026. The offering is expected to close October 1, 2026, subject to customary closing conditions. Cohen & Company Capital Markets acted as sole bookrunner.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags